NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation Copyright Public domain ✖Remove constraint Copyright: Public domain Recently Added Within 6 Months ✖Remove constraint Recently Added: Within 6 Months Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

13. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

15. CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
COVID-19 Testing -- instrumentation
Government Programs
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

16. CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Child Health
Government Programs
Government Regulation
Immunization Programs
Vaccines -- supply & distribution
United States
Centers for Disease Control and Prevention (U.S.)
Vaccines for Children (Program)

18. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

19. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):
Government Regulation
Managed Care Programs -- organization & administration
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

21. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

23. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

24. Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):
COVID-19
Government Regulation
Hispanic or Latino
Medicare
Telemedicine -- statistics & numerical data
Urban Population
United States

27. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry

Publication:
Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):
Blood Banking -- standards
Blood Donation -- standards
Blood Donors
Donor Selection -- standards
Government Regulation
Guideline Adherence
Plasma
United States

29. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.

30. The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2023
Subject(s):
Government Regulation
Medicare
Opiate Overdose -- prevention & control
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

35. Defense health care: Additional assessments needed to determine effects of active duty medical personnel reductions : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, July 2023
Subject(s):
Government Regulation
Health Workforce -- organization & administration
Legislation, Medical
Military Medicine -- organization & administration
United States
United States. Department of Defense

36. Defense health care: DOD assessment needed to ensure TRICARE behavioral health coverage goals are being met : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2023
Subject(s):
Behavioral Medicine
Government Programs
Government Regulation
Legislation, Medical
Mental Health Services
Military Family
Military Health Services
United States
United States. Department of Defense

41. Direct-to-consumer prescription drug advertisements: presentation of the major statement in a clear, conspicuous, and neutral manner in advertisements in television and radio format final rule : questions and answers : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, December 2023
Subject(s):
Direct-to-Consumer Advertising -- legislation & jurisprudence
Drug Industry
Government Regulation
Legislation, Drug
Prescription Drugs
United States

42. During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, October 2022
Subject(s):
Air Travel
COVID-19 -- prevention & control
COVID-19 -- transmission
Government Regulation
Personal Protective Equipment
Travel-Related Illness
United States
United States. Department of Health and Human Services

50. FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Government Regulation
Health Policy
Tobacco Control
Tobacco Industry -- legislation & jurisprudence
United States
United States. Food and Drug Administration

52. FDA’s approach to overseeing online tobacco retailers needs improvement

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):
Data Collection
Government Regulation
Tobacco Control
Tobacco Industry -- legislation & jurisprudence
Tobacco Products -- legislation & jurisprudence
Tobacco Products -- supply & distribution
United States
United States. Food and Drug Administration

54. Federal research: NIH could take additional actions to manage risks involving foreign subrecipients : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, June 2023
Subject(s):
Government Regulation
Legislation, Medical
Research Support as Topic -- organization & administration
Risk Management
SARS-CoV-2 -- isolation & purification
China
United States
Wuhan da xue
Zhongguo ke xue yuan. Wuhan bing du yan jiu suo
Jun shi yi xue ke xue yuan (China)
National Institutes of Health (U.S.)

55. The Food and Drug Administration needs to improve the premarket tobacco application review process for electronic nicotine delivery systems to protect public health

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Electronic Nicotine Delivery Systems -- supply & distribution
Government Regulation
Tobacco Control -- legislation & jurisprudence
United States
United States. Food and Drug Administration

56. For Medicaid-enrolled children diagnosed with lead toxicity in five states, documentation reviewed for diagnoses and treatment services raises concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):
Child
Data Accuracy
Government Regulation
Lead Poisoning -- diagnosis
Lead Poisoning -- prevention & control
Lead Poisoning -- therapy
Medicaid
United States

58. The future of remote patient monitoring

Author(s):
Harris, Julia, (Of Bipartisan Policy Center), author
Curtis, Mikayla, author
Sandalow, Maya, author
Hoagland, G. William, author
Serafini, Marilyn, author
Publication:
Washington, DC : Bipartisan Policy Center, January 2024
Subject(s):
Computer Security
Electronic Health Records
Government Regulation
Health Equity
Health Policy
Insurance, Health, Reimbursement
Medicaid
Medical Device Legislation
Medicare
Remote Sensing Technology
Telemedicine
United States

59. Healthy eating Rx: improving nutrition through health care

Author(s):
Glickman, Dan, author
Frist, William H., author
Shalala, Donna E., author
Veneman, Ann Margaret, 1949- author
Publication:
Washington, DC : Bipartisan Policy Center, November 2023
Subject(s):
Diet, Healthy
Food Assistance
Government Regulation
Health Policy
Nutrition Policy
Nutrition Therapy
United States
Supplemental Nutrition Assistance Program (U.S.)

60. High rates of prior authorization denials by some plans and limited state oversight raise concerns about access to care in Medicaid managed care

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
Subject(s):
Government Regulation
Health Services Accessibility
Managed Care Programs
Medicaid
Prior Authorization -- organization & administration
Prior Authorization -- statistics & numerical data
State Health Planning and Development Agencies
United States

61. Home health agencies failed to report over half of falls with major injury and hospitalization among their Medicare patients

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Accidental Falls
Accidental Injuries
Government Regulation
Home Care Agencies
Hospitalization
Mandatory Reporting
Medicare
Outcome Assessment, Health Care
Public Reporting of Healthcare Data
United States

64. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, October 2023
Subject(s):
Biological Products -- administration & dosage
Drug Dosage Calculations
Drug Industry
Drug Labeling
Drug Packaging
Government Regulation
Injections -- standards
Prescription Drugs -- administration & dosage
Product Labeling
Product Packaging
United States

65. In five states, there was no evidence that many children in foster care had a screening for sex trafficking when they returned after going missing

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2022
Subject(s):
Child, Foster
Foster Home Care
Government Regulation
Homeless Youth
Human Trafficking -- prevention & control
Mandatory Reporting
United States
National Center for Missing & Exploited Children (U.S.)

66. Inaccuracies in Medicare’s race and ethnicity data hinder the ability to assess health disparities

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2022
Subject(s):
Data Accuracy
Ethnicity
Government Regulation
Health Impact Assessment
Healthcare Disparities
Medicare -- organization & administration
Medicare -- statistics & numerical data
Racial Groups
United States

67. Indian Health Service: Actions needed to improve use of data on adverse events : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, July 2023
Subject(s):
American Indian or Alaska Native -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Outcome and Process Assessment, Health Care
United States
United States. Indian Health Service

68. Indian Health Service: Many federal facilities are in fair or poor condition and better data are needed on medical equipment : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, November 2023
Subject(s):
Equipment and Supplies
Facility Regulation and Control
Government Regulation
Health Facility Administration
Health Facility Environment
Legislation, Medical
United States
United States. Indian Health Service

69. Institutional review board (IRB) review of individual patient expanded access submissions for investigational drugs and biological products: guidance for IRBs and clinical investigators

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2023
Subject(s):
Biological Products
Compassionate Use Trials
Drug Industry
Drugs, Investigational
Ethics Committees, Research
Government Regulation
United States

70. Key strategies that states used for managing Medicaid and marketplace enrollment during the COVID-19 PHE

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
COVID-19
Eligibility Determination -- organization & administration
Government Regulation
Health Insurance Exchanges
Medicaid -- organization & administration
State Health Planning and Development Agencies
United States

73. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

76. Medicaid program integrity: Opportunities exist for CMS to strengthen use of state auditor findings and collaboration : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Financial Audit -- legislation & jurisprudence
Financial Audit -- trends
Government Programs
Government Regulation
Legislation, Medical
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

77. Medicaid: CMS oversight and guidance could improve Recovery Audit Contractor program : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, June 2023
Subject(s):
Contract Services -- legislation & jurisprudence
Financial Audit -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Medicaid -- legislation & jurisprudence
United States
Medicare Recovery Audit Contractor Program (U.S.)

81. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, September 19, 2023
Subject(s):
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Drugs -- economics
United States

82. Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Drug Costs
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

83. Medicare cognitive assessments: utilization tripled between 2018 and 2022, but challenges remain : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2023
Subject(s):
Alzheimer Disease
Government Regulation
Healthcare Disparities
Medicare
Mental Status and Dementia Tests -- statistics & numerical data
Neurocognitive Disorders
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

84. Medicare could save millions if it implements an expanded hospital transfer payment policy for early discharges to post acute care

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):
Financial Audit
Government Regulation
Medicare Part A -- economics
Medicare Part A -- organization & administration
Patient Transfer -- economics
Subacute Care -- economics
United States

86. Medicare: Performance-based and geographic adjustments to physician payments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, October 19, 2023
Subject(s):
Access to Primary Care -- statistics & numerical data
Government Regulation
Health Inequities
Health Promotion -- economics
Medicare
Primary Prevention
United States

87. Mental health services: State should collect ongoing feedback to ensure overseas employees’ needs are being met : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2023
Subject(s):
Foreign Professional Personnel -- psychology
Government Employees -- psychology
Government Regulation
Legislation, Medical
Mental Health Services
Workload
United States
United States. Agency for International Development

88. More than a thousand nursing homes reached infection rates of 75 percent or more in the first year of the COVID-19 pandemic: better protections are needed for future emergencies

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2023
Subject(s):
COVID-19 -- prevention & control
COVID-19 -- transmission
Disease Transmission, Infectious -- statistics & numerical data
Government Regulation
Nursing Homes -- organization & administration
Nursing Homes -- statistics & numerical data
United States

93. Nursing homes: Limitations of using CMS data to identify private equity and other ownership : report to the Ranking Member, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Data Accuracy
Government Regulation
Legislation, Medical
Nursing Homes -- economics
Nursing Homes -- legislation & jurisprudence
Nursing Homes -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)